Compare Motorola Solutions Inc (MSI) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Motorola Solutions Inc vs Natera Inc. Common Stock — how do they compare? Motorola Solutions Inc trades at $449.41 (market cap $74.31B), while Natera Inc. Common Stock trades at $394.6 (market cap $57.03B). The key difference: Motorola Solutions Inc is the larger of the two by market cap, and Motorola Solutions Inc pays a 1.08% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Motorola Solutions Inc for 101 Days and Natera Inc. Common Stock for 0 Days on average.
| MSI | NTRA | |
|---|---|---|
Market Cap | $74.31B | $57.03B |
Volume | 847,711 | 1,131,157 |
Sector | Technology | Health |
52-Week High | $491.24 | $425.64 |
52-Week Low | $363.83 | $179.42 |
Typical Hold Time | 101 Days | 0 Days |
Enterprise Value | $83.22B | $56.18B |
Dividend Yield | 1.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $451.49, up 1.19% with a neutral technical outlook. The stock shows strong fundamentals with consistent earnings beats, a record $15.6B backlog (Zacks, 2026-09-28), and robust profitability (17.44% net margin). Recent acquisitions like D-Fend Solutions expand its security footprint, while a $2B share repurchase boost signals confidence. Valuation ratios remain elevated with P/E at 35.38.
Outlook is positive driven by contract wins and AI integration, but high valuation and significant investing cash outflows ($-5.16B in 2025) pose risks. Analyst consensus is bullish (70.59% Buy) with a $525.86 price target, implying 16% upside. Key risks include execution of acquisitions and debt levels (debt-to-asset 47.29% in 2025).
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
